Investor Samfara buys Danish drug ingredient maker Chr. Olesen Synthesis
Samfara Acquirer · Chr. Olesen Synthesis Target · Chr. Olesen Seller · Signet Healthcare Partners Seller
Intelligence
The deal
- Type
- Buyout
- Amount
- Not disclosed
- Status
- Closed
- Valuation
- Not recorded
- Region
- Denmark
- Date
- 2 October 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Activity